Herpetic neuralgia
Conditions
Interventions
Experimental group:Interferon-a and lidocaine were injected into the target
Control group:The targets were injected with methylprednisolone sodium succinate and lidocaine
Sponsors
First Hospital of Shanxi Medical University
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Herpetic neuralgia with a course less than 3 months; 2.The trigeminal ganglion and cerviothoracic lumbosacral ganglion were involved, NRS > 4; 3.Aged 50 to 80 years, gender is not limited; 4.Volunteer to participate in the study and sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1.Herpes infection at the puncture site; 2.Herpez zoster oticus, central nervous system invasion and disseminated herpes zoster and other special clinical types; 3.Allergic to interferon alpha and methylprednisolone sodium succinate; 4.Coagulation dysfunction, severe heart, liver and renal insufficiency; 5.Patients with congenital immunodeficiency or immunodeficiency and serious diseases such as tuberculosis and tumor; 6.Patients with poor coordination with mental disorders (including patients cannot perform NRS and sleep quality scores); 7.The researcher did not consider it appropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numeric rating scale;Incidence of postherpetic neuralgia; | — |
Secondary
| Measure | Time frame |
|---|---|
| PSQI;Number of nerve block treatments;Total dose of basic drugs; | — |
Countries
China
Contacts
Public ContactXue Zhaoxia
First Hospital of Shanxi Medical University
Outcome results
None listed